|
|
楼主 |
发表于 2025-2-6 15:36:45
|
显示全部楼层
本帖最后由 NatureBoy 于 2025-2-6 16:03 编辑 9 d% z, W/ C$ G2 ~
7 U; d! a5 q; S: k2 b
今年的ISC大会Late-Breaking Science（重磅研究）已经出炉，国内单位入选情况# ^5 C$ s: g% a$ s
) D+ u( z, ?. l4 A
LB2. TransRadial versus transfemoral Arterial access for CErebral angiography
) R! |8 R" A) O) M* a" SWei Ni, Huashan Hospital, Fudan University, Shanghai, China
' s2 ~% S. B9 j% x3 ?: x a$ y9 A0 x" S$ z% p* h; @
LB17. Intensive Blood Pressure Lowering After Thrombectomy in Ischemic Stroke Patients-A Randomized Clinical Trial, h+ L3 ?2 J5 G3 c
Xuening Zhang, West China Hospital, Sichuan University, Chendu, China0 N8 l7 Y; H8 |( n5 O h: J8 R/ r
1 f8 t7 ~5 \. T4 n6 |
LB38. Intra-arterial Tenecteplase thrombolysis for acute LVO after successful mechanical thrombectomy recanalization (ANGEL-TNK) — A Multicenter, Prospective, Randomized, Open-label, Blinded End-point Trial
+ r* S. X) p- U" X( s& j% k& T; Q3 y" g$ F; EMiao Zhongrong, Beijing Tiantan Hospital, Beijing, China
d; F# i' g" B' L- V- L3 B- n! Q, M$ a
LB39. The Optimal Dosage of ADjunctive Intra-Arterial Tenecteplase following Successful Endovascular Thrombectomy in Patients with Large Vessel Occlusion Acute Ischemic Stroke (DATE) Trail& f) M m; u" \
Xianhua Hou, The First Affiliated Hospital, Army Medical University, Chongqing, China" K+ [( K5 f$ u: J
/ |8 \2 a5 u; E' A# o5 D
LB41. Treatment with intravenous alteplase in ischemic stroke patients with onset time between 4.5 and 24 hours8 A, Q0 I2 K! x; j0 C
Min Lou, The Second Affiliated Hospital of Zhejiang University, School of Medicine, Hangzhou, China
. U: P$ z3 _0 w% o, Z
- n) x) O. Q* q% t! [LB42. Intra-arterial Alteplase for Acute Ischemic Stroke After Mechanical Thrombectomy (PEARL): A Multicenter Randomized Trial
, C1 j( p/ N- y0 W* FYamei Tang, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China
) W4 D6 }$ A4 ~) g9 w* L) J6 ^
% q1 f! W4 @0 ULB44. Liraglutide in Acute Minor Ischemic Stroke or High-risk Transient Ischemic Attack Patients with Type 2 Diabetes Mellitus (LAMP): A Randomized Clinical Trial
$ f( M: \( l0 F8 E" V! b8 V RHuili Zhu, The First Affiliated Hospital of Jinan University, Guangzhou, China5 d% ^' s+ ]# }' _
8 F6 G& c+ f, Q$ I
LB45. BXOS110 for Acute Ischemic Stroke Treatment (BEST): A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial
5 i" {. D! l* m9 r) b4 @- IYarong Ding, Beijing Tiantan Hospital, Beijing, China
. w0 m, d, B$ S+ s! }
. Y3 l. f/ C R0 n祝贺以上单位！/ o! s5 d: j2 x* R0 e, `
|
|
发表于 2025-2-6 15:11:41
发表于 2025-2-6 15:40:38
